# ARS Pharmaceuticals, Inc.: Form SC 13D/A, filed Nov 30, 2022

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: SC 13D/A
- Filed: 2022-11-30
- Accepted by EDGAR: Nov 30, 2022, 16:23 ET
- Period: not reported
- Accession: 0000947871-22-001216
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000094787122001216/ss1560754_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000094787122001216/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000094787122001216/ss1560754_sc13da.htm

Filed Nov 30, 2022.
Source: SEC EDGAR, the filing index for accession 0000947871-22-001216. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
